Pharmacologic treatment for detrusor overactivity

H. Henry Lai; Timothy B. Boone; Rodney A. Appell

doi:10.1007/s11934-002-0078-4

Pharmacologic treatment for detrusor overactivity

H. Henry Lai, Timothy B. Boone, Rodney A. Appell

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Recent pharmacologic treatment for detrusor overactivity has resulted in more favorable side effect profiles, not only because of the use of different drug delivery systems for older drugs but perhaps also due to the improved bladder selectivity of newer antimuscarinic agents. These developments translate into higher patient compliance and better long-term results with the newer agents over generic immediate-release oxybutynin for the treatment of the overactive bladder.

Original language	English
Pages (from-to)	365-372
Number of pages	8
Journal	Current urology reports
Volume	3
Issue number	5
DOIs	https://doi.org/10.1007/s11934-002-0078-4
State	Published - Sep 2002

Keywords

Detrusor Overactivity
Overactive Bladder
Oxybutynin
Tolterodine
Urge Urinary Incontinence

Access to Document

10.1007/s11934-002-0078-4

Cite this

@article{df991a56997749369bca52f1877ca6cb,

title = "Pharmacologic treatment for detrusor overactivity",

abstract = "Recent pharmacologic treatment for detrusor overactivity has resulted in more favorable side effect profiles, not only because of the use of different drug delivery systems for older drugs but perhaps also due to the improved bladder selectivity of newer antimuscarinic agents. These developments translate into higher patient compliance and better long-term results with the newer agents over generic immediate-release oxybutynin for the treatment of the overactive bladder.",

keywords = "Detrusor Overactivity, Overactive Bladder, Oxybutynin, Tolterodine, Urge Urinary Incontinence",

author = "Lai, {H. Henry} and Boone, {Timothy B.} and Appell, {Rodney A.}",

note = "Publisher Copyright: {\textcopyright} 2002, Current Science Inc.",

year = "2002",

month = sep,

doi = "10.1007/s11934-002-0078-4",

language = "English",

volume = "3",

pages = "365--372",

journal = "Current urology reports",

issn = "1527-2737",

number = "5",

}

TY - JOUR

T1 - Pharmacologic treatment for detrusor overactivity

AU - Lai, H. Henry

AU - Boone, Timothy B.

AU - Appell, Rodney A.

PY - 2002/9

Y1 - 2002/9

N2 - Recent pharmacologic treatment for detrusor overactivity has resulted in more favorable side effect profiles, not only because of the use of different drug delivery systems for older drugs but perhaps also due to the improved bladder selectivity of newer antimuscarinic agents. These developments translate into higher patient compliance and better long-term results with the newer agents over generic immediate-release oxybutynin for the treatment of the overactive bladder.

AB - Recent pharmacologic treatment for detrusor overactivity has resulted in more favorable side effect profiles, not only because of the use of different drug delivery systems for older drugs but perhaps also due to the improved bladder selectivity of newer antimuscarinic agents. These developments translate into higher patient compliance and better long-term results with the newer agents over generic immediate-release oxybutynin for the treatment of the overactive bladder.

KW - Detrusor Overactivity

KW - Overactive Bladder

KW - Oxybutynin

KW - Tolterodine

KW - Urge Urinary Incontinence

UR - http://www.scopus.com/inward/record.url?scp=1842848116&partnerID=8YFLogxK

U2 - 10.1007/s11934-002-0078-4

DO - 10.1007/s11934-002-0078-4

M3 - Article

C2 - 12354344

AN - SCOPUS:1842848116

SN - 1527-2737

VL - 3

SP - 365

EP - 372

JO - Current urology reports

JF - Current urology reports

IS - 5

ER -

Pharmacologic treatment for detrusor overactivity

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this